Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:PFE)

U.S. FDA Approves Pfizer's BEQVEZ(TM) (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B

Business Wire 8 hours ago

Pfizer Declares Second-Quarter 2024 Dividend

Business Wire 1 day ago

European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options

Business Wire 4 days ago

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

Business Wire April 11, 2024

Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease

Business Wire April 9, 2024

ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager

PR Newswire April 8, 2024

Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts

Business Wire March 20, 2024

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease

Business Wire March 13, 2024

Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Business Wire March 12, 2024
View More News ››

Opinion & Analysis (NYSE:PFE)

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

Stockhouse Editorial July 29, 2020

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

Stockhouse Editorial June 18, 2020

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Omri Wallach March 19, 2020

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

Streetwise Reports July 31, 2019

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Streetwise Reports July 9, 2019

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017
View More Opinion ››

Bullboard Posts (NYSE:PFE)

RE:The dividend of $0.42

Yeah Pfe has been a disaster. I'm done averaging down on this one. Seems there getting lawsuits thrown at them every second day. ...
barneyj44 - 15 hours ago

The dividend of $0.42

Does not cover today's loss  nothing else to add  dyodd
ecolo101 - 22 hours ago

Last 6 months

From $31 to $26...can this boat be stabilized? hopefully R&D behind it will come up with something new and important for global...
ecolo101 - 2 days ago

The 50D SMA

Is $27.11 . Let's hope we cross It this week and walk on 200D SMA at $30.74. Then after we build on sounded ground toward $35. glta...
ecolo101 - 3 days ago

Patience patience

When it will start going up it will be for the long run.....hopefully  Q1 results later this week. Let's hope we see some clear...
ecolo101 - 4 days ago

What is management doing?

I can't understand what is going on? Waiting for the next board meeting to discuss salary at their level? shareholders are not...
ecolo101 - 9 days ago
View more Bullboard ››

New Pacific Metals Corp.

New Pacific Metals Corp.

New Pacific Metals Corp. is a Canada-based exploration and development company, which is focused on three precious metal ...
View More »